Not Yet RecruitingNot Applicable

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

120 participantsStarted 2025-09

Plain-language summary

Albumin/globulin ratio and platelet/albumin ratio as a predictive non-invasive biomarker for lupus nephritis (LN) presence and severity

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 years or older diagnosed as SLE according to 2019 ACR/EULAR classification criteria and with lupus nephritis (LN) according to the ACR criteria. * Patients with available baseline laboratory investigations and renal biopsy. Exclusion Criteria: * Patients with chronic liver disease, hematological disorders, or malignancies affecting albumin/globulin ratio or platelet counts. * Patients on nephrotoxic medications not related to SLE management. * Recent infections or acute inflammatory conditions.

What they're measuring

Association of Albumin/Globulin (A/G) and Platelet/ Albumin (P/A) ratios with the presence of lupus nephritis

Timeframe: baseline

Compare the Albumin/Globulin (A/G) and Platelet/Albumin (P/A) ratios between different classes of lupus nephritis

Timeframe: baseline

Trial details

NCT IDNCT07130448

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09

Contact for this trial

Mina Maged William

+201020910834 Mena.17289637@med.aun.edu.eg

View on ClinicalTrials.gov More Lupus Nephritis (LN) trials